key: cord-0703655-waa8lekk authors: nan title: The Zika Virus Individual Participant Data Consortium: A Global Initiative to Estimate the Effects of Exposure to Zika Virus during Pregnancy on Adverse Fetal, Infant, and Child Health Outcomes date: 2020-09-30 journal: Trop Med Infect Dis DOI: 10.3390/tropicalmed5040152 sha: 1e68cb700d9c031cc1fff3791ddaec8896c660bc doc_id: 703655 cord_uid: waa8lekk This commentary describes the creation of the Zika Virus Individual Participant Data Consortium, a global collaboration to address outstanding questions in Zika virus (ZIKV) epidemiology through conducting an individual participant data meta-analysis (IPD-MA). The aims of the IPD-MA are to (1) estimate the absolute and relative risks of miscarriage, fetal loss, and short- and long-term sequelae of fetal exposure; (2) identify and quantify the relative importance of different sources of heterogeneity (e.g., immune profiles, concurrent flavivirus infection) for the risk of adverse fetal, infant, and child outcomes among infants exposed to ZIKV in utero; and (3) develop and validate a prognostic model for the early identification of high-risk pregnancies and inform communication between health care providers and their patients and public health interventions (e.g., vector control strategies, antenatal care, and family planning programs). By leveraging data from a diversity of populations across the world, the IPD-MA will provide a more precise estimate of the risk of adverse ZIKV-related outcomes within clinically relevant subgroups and a quantitative assessment of the generalizability of these estimates across populations and settings. The ZIKV IPD Consortium effort is indicative of the growing recognition that data sharing is a central component of global health security and outbreak response. While the world has turned to face COVID-19, recent epidemics are re-emerging [1, 2] . Even as vector control is sidelined to confront the current crisis [3] , close to 3 billion Zika virus (ZIKV) naïve people live in Aedes-aegypti endemic areas in Asia and Africa [4] . Despite the advances in ZIKV research, researchers are only now beginning to characterize the longer-term sequelae of fetal ZIKV exposure [5, 6] . Identification of factors that affect the risk of fetal infection and adverse pregnancy, birth, and pediatric developmental outcomes is central to quantifying the burden of disease related to ongoing and future ZIKV transmission and critical for the development of diagnostic assays, vaccines, appropriate early intervention strategies, and targeted preventive measures. In February 2017, a group of researchers formed the ZIKV Individual Participant Data (IPD) Consortium to conduct an individual participant data meta-analysis (IPD-MA) of ZIKV-related longitudinal studies of pregnant women and their children. The ZIKV IPD Consortium initiative arose from a meeting of international organizations and Ministries of Health in June 2016 to coordinate and harmonize ZIKV-related research efforts [7] . IPD-MA is the synthesis and analysis of participant-level data across related studies and provides a number of statistical and clinical advantages over aggregate data meta-analysis [8] . The research objectives of the ZIKV IPD Consortium IPD-MA are to (1) estimate the absolute and relative risks of miscarriage, fetal loss, and short-and long-term sequelae of fetal Zika Trop. Med. Infect. Dis. 2020, 5, 0152 2 of 8 exposure for women that experience symptomatic and asymptomatic ZIKV infection during pregnancy; (2) identify and quantify the relative importance of different sources of heterogeneity in the risk of adverse fetal, infant, and child outcomes among infants exposed to ZIKV in utero; and (3) develop and validate a prognostic prediction model [9] to identify high risk pregnancies and inform communication between health care providers and their patients and to optimize mobilization of resources (e.g., vector control strategies, antenatal care, and family planning programs). The IPD-MA will include data from longitudinal studies or country-level active surveillance systems that measure ZIKV exposure and infection during pregnancy and subsequent fetal, infant, and/or child outcomes. The full protocol for the IPD-MA is available from BMJ Open (https://bmjopen.bmj.com/content/9/6/e026092). As of August 2020, 52 cohort studies and country-level active surveillance system sites from 28 countries and territories have agreed to contribute de-identified data to the ZIKV IPD Consortium IPD-MA. The use of participant-level data from diverse geographies and populations will allow the team to better identify the clinical, virological, environmental, and individual-level factors that predict severe ZIKV-related fetal effects or adverse neurocognitive or neurodevelopmental outcomes in the child, several of which can only be measured after two years of age [10] . For example, the diversity of populations will help researchers understand differences in the sequelae of fetal exposure between populations with a high prevalence of recent prior exposure to other arboviruses and those where ZIKV occurs alone, while accounting for yellow fever immunization. Figure 1 shows the distribution of ZIKV cases at the global level, extracted from the PAHO PLISA Health Information Platform for the Americas [11] . Each circle represents a longitudinal study or country-level active surveillance system with circle size corresponding to the number of pregnant women enrolled and the line indicating the time period during which studies recruited pregnant women. As indicated in the graph, the number of new ZIKV cases has decreased dramatically since 2018, and several of the larger studies began towards the end of the epidemic in the Americas. Utilizing available data will be especially important since few studies have been able to secure funding for the follow-up needed to understand the spectrum and incidence of longer-term consequences of fetal exposure to ZIKV. The global response to ZIKV has been characterized by unprecedented levels of collaboration between countries, research organizations, universities, and surveillance systems [12] . The ZIKV IPD Consortium effort is indicative of the growing recognition that data sharing is a central component of global health security and outbreak response. Ideally, cross-study and cross-system data synthesis and analysis would take place in real time during an epidemic. To make that possible, the governance and systems for data and sample sharing need to be in place before the next major outbreak. Statistical methods for valid synthesis and analysis of large combined datasets in an IPD-MA need to be adapted to inform the public health response to emerging pathogens [13] , especially when there is no reference standard that can be used to evaluate the relative accuracy of different diagnostic assays [14] [15] [16] . Women living in and travelling to countries with ongoing or recent ZIKV transmission face a tremendous burden from the fear and uncertainty around the risks associated with ZIKV infections during pregnancy, guidance from public health authorities to avoid or delay pregnancy, and the lack of economic and social support for the challenges of raising infants with congenital Zika syndrome (CZS) and other ZIKV-related disabilities and developmental delays [17, 18] . Research study participants have the added burden of intensive follow-up that may require frequent blood draws and long commutes. While there is currently no vaccine or prophylaxis to prevent or mitigate the effects of ZIKV infection during pregnancy, leveraging data across studies to improve precision and developing the statistical methods needed to improve the accuracy and quantify the uncertainty of the information conveyed to families and health systems are ethical imperatives. Despite the persistent threat of ZIKV infection to pregnant women and women of reproductive age worldwide, investment in critical areas of ZIKV research is waning. Leveraging existing investments through collaboration will accelerate the development of effective prevention, harm reduction, and control strategies. Best practices and lessons learned from the research response to ZIKV can be used to improve the coordination and speed of the global research response to emerging pathogens. Platform for the Americas [11] . Each circle represents a longitudinal study or country-level active surveillance system with circle size corresponding to the number of pregnant women enrolled and the line indicating the time period during which studies recruited pregnant women. As indicated in the graph, the number of new ZIKV cases has decreased dramatically since 2018, and several of the larger studies began towards the end of the epidemic in the Americas. Utilizing available data will be especially important since few studies have been able to secure funding for the follow-up needed to understand the spectrum and incidence of longer-term consequences of fetal exposure to ZIKV. COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edge COVID-19 and dengue fever: A dangerous combination for the health system in Brazil The Impact of COVID-19 on Local Vector Control Response; National Association of County and City Health Officials Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: A modelling study Zika clinical updates Zika Virus as a Possible Risk Factor for Autism Spectrum Disorder: Neuroimmunological Aspects Harmonisation of Zika virus research protocols to address key public health concerns Meta-analysis of individual participant data: Rationale, conduct, and reporting Prognosis and prognostic research: What, why, and how? The INTERGROWTH-21st Project Neurodevelopment Package: A Novel Method for the Multi-Dimensional Assessment of Neurodevelopment in Pre-School Age Children Cases of Zika Virus Disease by Country or Territory (Weekly Case Report) Addressing the knowledge gaps and working towards a research preparedness network in the Evidence synthesis in prognosis research How variation in predictor measurement affects the discriminative ability and transportability of a prediction model Impact of predictor measurement heterogeneity across settings on the performance of prediction models: A measurement error perspective The influence of measurement error on calibration, discrimination, and overall estimation of a risk prediction model Women's lives in times of Zika: Mosquito-controlled lives? Cad. Saúde Pública Spontaneous Abortion Associated with Zika Virus Infection and Persistent Viremia The designations employed and the presentation of material in this information product do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) concerning the legal or development status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or products of manufacturers, whether or not these have been patented, does not imply that these have been endorsed or recommended by FAO in preference to others of a similar nature that are not mentioned.The views expressed in this information product are those of the author(s) and do not necessarily reflect the views or policies of FAO. Under the terms of this licence, this work may be copied, redistributed and adapted for non-commercial purposes, provided that the work is appropriately cited. In any use of this work, there should be no suggestion that FAO endorses any specific organization, products or services. The use of the FAO logo is not permitted. If the work is adapted, then it must be licensed under the same or equivalent Creative Commons licence. If a translation of this work is created, it must include the following disclaimer along with the required citation: "This translation was not created by the Food and Agriculture Organization of the United Nations (FAO). FAO is not responsible for the content or accuracy of this translation. The original [Language] edition shall be the authoritative edition."Disputes arising under the licence that cannot be settled amicably will be resolved by mediation and arbitration as described in Article 8 of the licence except as otherwise provided herein. The applicable mediation rules will be the mediation rules of the World Intellectual Property Organization http://www.wipo.int/amc/en/mediation/rules and any arbitration will be conducted in accordance with the Arbitration Rules of the United Nations Commission on International Trade Law (UNCITRAL).Third-party materials. Users wishing to reuse material from this work that is attributed to a third party, such as tables, figures or images, are responsible for determining whether permission is needed for that reuse and for obtaining permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.Sales, rights and licensing. FAO information products are available on the FAO website (www.fao.org/publications) and can be purchased through publications-sales@fao.org. Requests for commercial use should be submitted via: www.fao.org/contact-us/licence-request. Queries regarding rights and licensing should be submitted to: copyright@fao.org.© 2020 by World Health Organization; Licensee MDPI, Basel, Switzerland. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organisation or products. The use of the WHO logo is not permitted.